2018 Rexall OneWalk to Conquer Cancer benefiting Princess Margaret Cancer Centre


Cancer immune therapy is based on the principle that by properly stimulating the immune system, we can harness the true power of the human immune system to fight cancer. Perhaps the most promising new cancer treatment approach since the development of the first chemotherapies, cancer immune therapies have the potential to achieve complete, long-lasting remissions and cancer cures.
Since 2009, Tumourslayers (formerly the Campbell Family LaBRAtory Ladies & Lads team) have raised over $123,000 for The Rexall OneWalk™ to Conquer Cancer benefiting the Princess Margaret Cancer Centre. Representing the Campbell Family Institute for Breast Cancer Research, our team members come from research laboratories that are investigating ways of enhancing our natural immune response against cancer in an effort to develop novel immune therapeutics. Your generous donations will support research into promising initiatives in the area of immune therapy as well as an exciting clinical trial of the anti-cancer drug, CFI-400945 (PLK-4 inhibitor). The Campbell Family Institute for Breast Cancer Research have an excellent track record of research in immunology, oncology and translational science, and your donations will make a significant difference in the battle against cancer.
We all know someone who has been touched by cancer, and The Rexall OneWalk™ to Conquer Cancer benefiting the Princess Margaret Cancer Centre is a huge step towards conquering cancer once and for all. On September 7th, 2018 Tumourslayers will be joined by thousands of women and men to walk 15 km through the streets of Toronto; each step bringing us closer to changing the future for those touched by cancer.
We are very proud to be part of the Princess Margaret Tumourslayers, and we ask you to take a stand with us. Be a part of our very personal journey - by giving, by walking with us, or simply by sharing our story. We have the opportunity to change thousands of lives, beginning with our own.
This isn’t just our journey – it’s yours, too.

View More